TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

Parallel graph neural networks identify protein-ligand 3-D structural interactions to aid in protein function prediction and drug discovery.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

The scientist behind the online cartoon RedPen/BlackPen explains how humor can build bridges between scientists and the public.

PNNL scientists are protecting first responders and others by expanding what’s known about fentanyl, the driver of the opioid epidemic.

Researchers characterize protein signatures that indicate Acute Kidney Injury in COVID-19 patients.

Simulations reveal advantages of using new model vs. allometric scaling for risk assessment.

PNNL scientists publish paper and host workshops to share threat-agnostic vision for biodefense.

A multi-institutional team has developed a deep learning framework to identify novel molecules as drug candidates.

Scientists have devised a way to engineer yeast to produce sustainable, eco-friendly commodity chemicals using computing power as a guide.

The nested nanoPOTS chip is the next generation of technology developed at PNNL to prepare single cells for proteomics.

Researchers map nearly 9,000 proteins in the human lungs, providing a clearer picture of development.

A study of Middle East Respiratory Syndrome has identified a compound that shows potential in easing the symptoms of coronavirus infections.

Mary Lancaster, epidemiologist and data scientist, co-authored a chapter on cyberbiosecurity for the NATO Science for Peace and Security book series.

PNNL data scientists are refining their artificial intelligence tools with COVID-19 data to advance therapeutics and treatments for a future pandemic.

Hypergraphs can more faithfully identify important genes in complex immune responses.

A Q&A with Lauren Charles, veterinarian and PNNL data scientist, on zoonotic diseases and the role biosurveillance plays in mitigating the growing threat to global health.

PNNL researchers are forming a clearer picture of how plant matter is transformed in the microbial gardens created by leaf-cutter ants.